Mr. Gerri Greenham reports

SOLARVEST BIOENERGY INC. CLOSES $655,500 SECOND TRANCHE OF FINANCING

Solarvest Bioenergy Inc. has closed the second tranche of its previously announced financing.

The company has now closed the financing, having raised gross proceeds from both tranches totalling $1,095,500 through the issuance of 5,477,500 units.

With respect to the second tranche, gross proceeds of $655,500 were raised through the issuance of 3,277,500 units at a price of 20 cents per unit. Each unit consists of one common share and one whole share purchase warrant. Each whole warrant will entitle the holder to purchase one additional common share of the company at a price of 25 cents per share for a period of three years following closing. The company has paid a cash commission of $32,640 and issued 163,200 whole share purchase warrants on the same terms of the financing.

The company previously closed the initial tranche of the financing in the amount of $440,000, as described in the company's news release dated Nov. 13, 2018.

The proceeds will be used for the production of inventory, sales and marketing, equipment purchases, patenting costs and general working capital. All securities issued pursuant to the financing are subject to resale restrictions for a period of four months and one day from closing under applicable securities legislation.

About Solarvest Bioenergy Inc.

Solarvest Bioenergy is an algae technology company with an algal-based production platform that provides it with an extremely flexible system capable of being adapted to produce numerous products -- from omega-3 fatty acids to human therapeutic proteins. The company has successfully demonstrated (please see news release dated March 16, 2015) the expression of BMP, a high-value therapeutic protein.

We seek Safe Harbor.